• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • About Us
  • Contact Us
  • Billing Portal
SPRINT® PNS System

SPR Therapeutics

SPRINT PNS System

  • Product
  • For Physicians
    • Clinical Outcomes & References
    • Implant Procedure Videos
    • Video Resources
    • SPRcare Reimbursement
    • Important Safety Information
    • MRI Safety Information
  • For Patients
    • Patient Stories
    • Patient Resources
    • Recursos para pacientes
    • MicroLead™ Safety
    • MRI Safety Information
  • Clinical Trials
  • News & Events
    • News
    • Events
    • Press Room
  • Careers

Tips for Incorporating SPRINT PNS into Your Pain Care Continuum

October 22, 2020
SPRINT PNS System

“The SPRINT System allows us to rethink our pain strategy and offer a first-line PNS option to our patients prior to more invasive or more permanently implanted options.” – Dr. Tim Deer

With a variety of options for treating pain, how do you explain to a patient that peripheral nerve stimulation (PNS) may be right for them? Below are some key points to keep in mind when working with a patient who is considering PNS.

1. Identify the right patient

SPRINT PNS is an innovative pain treatment option today. One that has been (and continues to be) clinically studied for a variety of chronic pain syndromes.

The SPRINT PNS System is indicated for use in the back and/or extremities for chronic or acute pain. Physicians should use their best judgment when deciding when to use the SPRINT PNS System.

Examples of how the SPRINT PNS System has been used commercially include:

  • Complex regional pain syndrome
  • Neuropathic mononeuropathy
  • Low back pain
  • Inoperable joint pain
  • Post-amputation pain
  • Nerve or plexus trauma
  • Meralgia Paresthetica
  • Post-operative joint/joint-replacement pain
  • Post-herniorrhaphy pain (posterior approach)
  • Post decompression/transposition surgery

The patient’s mindset and living conditions are also important.  SPRINT is best for patients who:

  • Prefer a motor sparing option that may preclude the need for a permanent implant
  • Desire a low-risk option early in the care continuum – often after their first visit
  • Can understand and comply with the 60-day treatment plan
  • Have the ability to change their dressing/bandage as needed, or who have a family member to assist

2. Explain the pain treatment continuum and how PNS fits into it

Patients seeking pain relief typically aren’t pain experts. They may not understand how the pain treatment continuum works, or all the steps it includes. They often don’t know how the different options for treating pain work or the risks and benefits associated with them. And they may not understand how a minimally-invasive PNS treatment like SPRINT PNS can fit within the journey.

Patients are usually more familiar with pain treatments such as radiofrequency ablation (RFA) or nerve blocks. Data have shown that once a patient understands the pros and cons of different treatment options, percutaneous 60-day PNS is often preferred. In fact, a recent survey of patients found that when presented with radiofrequency ablation and SPRINT PNS, 62% of the surveyed patients preferred SPRINT PNS because it was a non-destructive, motor-sparing temporary implant.

“The SPRINT PNS System has fostered a significant evolution within neuromodulation to include its unique role as a first-line PNS option. My patients love that they don’t have to default to a device that’s implanted for the rest of their life.” – Shalini Shah, MD

Because PNS is still a relatively new treatment option to patients, it’s important to walk the patient through their pain treatment options and ensure they understand that PNS can offer them a less-invasive option for chronic pain relief.

3. Connect the benefits of PNS to the patient’s health and lifestyle history

While various options for treating pain exist, some, especially surgery, may not be right for certain patients based on age, other existing health conditions or past experiences with either surgery or prescriptions. This is part of why PNS is a game-changer. PNS is often a less-invasive option for treating pain.

“In the last two years it’s probably been one of the most exciting new therapies for me and the partners in our practice, because we’re treating things that we never treated before,” said Dr. Henry Vucetic. “We’re giving patients new options [where in the past] we would’ve said, ‘Sorry, we don’t have anything else.’”

In another study of patients who have a history of using opioids for pain relief, it was found that PNS may help reduce opioid consumption. Dr. Christopher Gilmore recently attested to the positive impact of SPRINT as a treatment option, explaining how in a recent study it had helped reduce the use of opioids in chronic low back pain patients:

“We looked at participants who were taking opiates and their response to 60 days of treatment with SPRINT medial branch nerve stimulation in the lumbar region. Five months after initiation of treatment, 73% of participants had at least half of their opioid doses reduced. I had one participant who was taking 80 milligrams of morphine a day reduced to 0 at the end of treatment. And that was maintained out for three months post end of treatment.”

Dr. Nirav Shah also shared the way SPRINT PNS may fit within a pain relief care continuum as a preliminary approach to surgery.

“I’ve used this technology to actually wean patients down from opiates before surgery”.

For further clinical reading, read this piece on how SPRINT PNS helped reduce opioid consumption in chronic low-back pain patients.

4. How to Talk to Your Patients About SPRINT PNS

All the above are great things to keep in mind as you consider PNS for a patient. If you do decide that a patient may benefit from PNS, here are some helpful talking points for discussing the SPRINT PNS System with your patient.

  • SPRINT PNS is a minimally-invasive treatment option. Unlike many other options, SPRINT PNS does not involve a permanent implant or nerve and tissue destruction.
  • SPRINT PNS is a short-term, 60-day treatment that can provide significant and sustained pain relief that endures long after lead withdrawal.  Patients can continue performing most daily activities while avoiding bathing.
  • The device sends mild electrical pulses to the nerves, which can help provide relief. Also, the level of stimulation is controllable by the patient via a hand-held remote – the patient is in control at all times.
  • Across 30+ publications, 75% of patients reported significant and sustained pain relief.

After talking to a patient about SPRINT PNS, you can refer patients to download this helpful informational brochure or suggest they watch one of our SPRINT PNS patient story videos.


The SPRINT PNS System is indicated for up to 60 days in the back and/or extremities for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region.

Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

Share this post:

Share on Twitter Share on Facebook Share on LinkedIn Share on SMS Share on Email
Category: NewsTag: choosing a patient for PNS, pain care, pain care continuum, pain physician, pain relief, pain treatment, PNS, SPRINT PNS
Previous Post:SPRINT PNS Regional Training Lab- Austin, TX
Next Post:Percutaneous PNS for Low Back Pain Following RFA Research, SPRINT PNS at 2021 AAPMR Annual Meeting

Sidebar

Archives

Recent News

SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference

SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Dr. Samir Sheth discusses how the SPRINT® PNS System has impacted his approach to treating patients with chronic head and neck pain

SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022

A Discussion on Pain Management Options for Patients with Breast Cancer with Dr. Amitabh Gulati

Tags

60-day percutaneous PNS acute pain Back Pain back pain treatment cancer pain chronic back pain Chronic Pain clinical study Dr. Mehul Desai drug-free EY award hip pain low back pain medial branch Neuromodulation Non-opioid oncological pain opioid alternative Pain pain appointment pain physician pain relief pain treatment Patients Patient Story peripheral nerve stimulation permanent PNS implant phantom limb pain PNS PNS training post-amputation pain Press release radiofrequency ablation recondition CNS reduced opioids research Research study residual limb pain RFA Shoulder Pain SPRINT PNS SPRINT PNS System temporary pns Training lab webinar
SPRINT® PNS System

22901 Millcreek Blvd, Suite 500
Cleveland, OH 44122
(844) 378-9108 Phone
(216) 803-0777 Fax

Top Work Places 2022

Quick Links

  • Product
  • For Physicians
  • For Patients
  • Clinical Trials
  • News & Events
  • Careers
  • About Us
  • Contact Us

Legal Links

  • Privacy Statement
  • Terms of Use
  • CPRA Requests
  • Important Safety Information
  • Compliance
  • FCOI Policy
  • Product Terms & Conditions
  • Patent Information

Recent News Headlines

SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference

SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Dr. Samir Sheth discusses how the SPRINT® PNS System has impacted his approach to treating patients with chronic head and neck pain

SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View References for support of all claims.

The SPRINT® PNS System, MicroLead™, OnePass Introducer™, Rethink Your Pain Strategy™, Outsmart Pain™, Sustained Pain Relief Starts Here™, Life. Get Back to It.™ and SPR® are registered or common law trademarks of SPR Therapeutics, Inc.


Copyright © 2023 SPR Therapeutics. All Rights Reserved.

This website is intended only for US and Canadian residents 18 years of age and older. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo